Digital & Innovation

Digital health accelerator reveals first cohort

Health Industry Hub | December 10, 2021 |
[Total: 1    Average: 4/5]

Digital & Innovation: Australia’s only not-for-profit digital health commercialisation organisation, ANDHealth announced the five companies selected to take part in its Medical Research Future Fund (MRFF) funded ANDHealth+ program.

ANDHealth CEO, Bronwyn Le Grice, said “ANDHealth+ is the only digital health commercialisation acceleration program in Australia with proven impact and outcomes. These five companies have successfully navigated an exhaustive process designed to identify the teams and technology with the greatest chance of commercial growth and positive impact for patients in Australia and around the world.”

Announced at the ANDHealth Summer Summit 2021-22 by Dr Katie Allen, MP, the 2022 ANDHealth+ cohort includes:

  • Cardihab – Digital Cardiac Rehabilitation providing care to patients at a time and place that works for them.
  • Gheorg – The friendly robot helping children with anxiety; an AI enhanced first responder for children with mental health issues and expert guide for parents.
  • Perx Health – A motivation and engagement platform changing the way people and companies create habits for managing medical conditions.
  • Sound Scouts – Free online hearing test app for kids. Fun, clinically proven technology enabling hearing to be checked efficiently and reliably.
  • VaxApp – An immunisation management platform that enables healthcare providers to deliver and monitor vaccination and rapid antigen testing programs.

The five companies selected in the first ANDHealth+ cohort will share in a pool of $3.75M of project funding via the ANDHealth Digital Health Accelerator Fund and over $500k of pre-screened expert professional services.

Helen Souris, CEO at Cardihab, said “I have been consistently impressed by the expertise and passion of the ANDHealth team, the calibre and insight of speakers and programs they host, and the results of companies that were in past cohorts of the ANDHealth+ Program. They are knowledgeable and enthusiastic about the promise of what the program could deliver. All these elements combined inspire confidence in the program and belief in the ability to succeed.”

Louise Metcalf, Founder and CEO of Gheorg, noted “ANDHealth is an incredible ace for us, it gives us a way to fulfil our mission to build the kind of mental health tech that health professionals will feel comfortable referring to, and that will be a world first. The whole process so far has been incredibly beneficial for us. The application alone really helped clarify where we were at and our needs as a science-based organisation.”

Luke Renehan, CEO at VaxApp, commented “It is an incredible opportunity for VaxApp to access key partners, networks, advisors, investors and potential clients, both in Australia and internationally. It’s been a great experience so far with the application process, it just shows the reach of ANDHealth and the value the partners put on the program.”

Le Grice added “Through ANDHealth+, these companies will have access to both Australian and international digital health experts with the specialised skills and real-world experience necessary to support the commercialisation of digital health interventions that underpin better health outcomes and allow Australia to build a globally competitive digital health industry.”

The inaugural cohort announcement follows ANDHealth+ receiving $19.75M in funding from the Australian Government’s MRFF Early-Stage Translation and Commercialisation Initiative in August. The funding will be used by ANDHealth to run four cohorts of ANDHealth+ over four years.

Based on the past performance of companies that participated in the smaller ANDHealth+ Pilot Program, ANDHealth+ cohorts in the next four years can expect to create 1,000 jobs, impact over 500,000 patients, undertake 175 clinical trials, raise over $130M in new financing and generate $80M in new revenues over the next eight years.

Over 120 companies expressed interest in the program, with 58 completing the comprehensive application process. The five companies selected were assessed through a rigorous process by a multi-sectoral, multi-disciplinary panel of industry leaders and approved by ANDHealth’s recently announced International Investment Advisory Committee.

Human Resources

Only 29% of employees say their leader shows ‘human leadership’

Health Industry Hub | June 24, 2022 |

Human Resources: A survey of more than 230 HR leaders revealed that 90% believe that to succeed in today’s work environment, […]


News & Trends - Medical Technology

MedTech News - Quantum HealthCare appointed as ANZ distributor for new medical technology

Quantum HealthCare appointed as ANZ distributor for new medical technology

Health Industry Hub | June 24, 2022 |

MedTech News: Alfred Health Hospital in Australia is set to receive first-in-nation portable MRI systems for point-of-care brain scans. US-based […]


News & Trends - Medical Technology

Medtech News - Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Health Industry Hub | June 24, 2022 |

MedTech News: The Australian Medical Association (AMA) is involved in proceedings before the Australian Competition Tribunal, opposing an attempt by […]


News & Trends - Medical Technology

Medtech News -

Medtronic award winner secures approval in diagnosis of gut disorders

Health Industry Hub | June 24, 2022 |

MedTech News: New Zealand based company and winner of the inaugural Medtronic APAC Innovation Challenge (MAIC) has received FDA approval […]


This content is copyright protected